| Jessica Marie Vessey, | |
|
1813 Sumner Ave, Aberdeen, WA 98520-4600 | |
| (360) 538-1461 | |
| (360) 537-4202 |
| Full Name | Jessica Marie Vessey |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1813 Sumner Ave, Aberdeen, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841767126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 60098078 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Marie Vessey, Po Box 34703, Seattle, WA 98124-1703 Ph: (206) 764-0502 | Jessica Marie Vessey, 1813 Sumner Ave, Aberdeen, WA 98520-4600 Ph: (360) 538-1461 |
News Archive
Catholic Healthcare West (CHW) President/CEO Lloyd H. Dean unveiled a multi-faceted campaign today aimed at pushing health care reform in Washington to a successful conclusion. CHW's "September for Reform" will bring the resources of one of America's largest hospital systems to bear on the national health care reform debate with a focus on urging members of Congress and the Obama Administration to accomplish reform this fall.
Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP, has signed a Memorandum of Understanding (MOU) representing the intention of the Company along with the United States Agency for International Development to step up the fight against the health threat of antibiotic-resistant bacteria.
Emergent BioSolutions Inc. today announced that it has been awarded five separate grants under the Qualifying Therapeutic Discovery Project (QTDP) Program to support continued development of its therapeutic programs in oncology and autoimmunity. The grants, with a total value of over $1.2 million, will fund Emergent's TRU-016 Small Modular ImmunoPharmaceutical (SMIP™), DRACO anti-CD3 SMIP, X1 TNF-based SCORPION™, X2 CTLA4-based SCORPION, and T-Scorps-based SCORPION therapeutic programs.
Multisite findings support the use of endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal lymph node sampling.
› Verified 3 days ago
Kelli Alexander, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2700 Simpson Ave Ste 101, Aberdeen, WA 98520 Phone: 360-612-0012 Fax: 360-532-0670 | |
Erin Pickar, CDPT Counselor Medicare: Not Enrolled in Medicare Practice Location: 516 E 1st St, Aberdeen, WA 98520 Phone: 360-350-4010 | |
Michael William Bromley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 224 E Wishkah St, Aberdeen, WA 98520 Phone: 360-556-8544 | |
Nicholas W Peters, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2700 Simpson Ave, Aberdeen, WA 98520 Phone: 360-612-0012 Fax: 360-352-0670 | |
Veronica Xena Rose Bradley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 403 W State St Ste 206, Aberdeen, WA 98520 Phone: 360-589-9068 Fax: 360-637-9132 | |
Sherwin Phillips, Counselor Medicare: Not Enrolled in Medicare Practice Location: 311 S I St, Aberdeen, WA 98520 Phone: 360-787-9319 | |
Tamara Meshell Morris, LCSWA Counselor Medicare: Not Enrolled in Medicare Practice Location: 224 E Wishkah St, Aberdeen, WA 98520 Phone: 360-532-9050 |